Issue Brief More than 2 million pregnant women will be potentially at risk from Zika this summer and fall.
Report States should take the lead in implementing innovative cost control and quality improvement reforms.
Topher Spiro and Lanhee Chen discuss the bipartisan benefits of investing in nurse coaching programs.
Issue Brief Experiences from past mergers show that divestitures most likely will not be a successful remedy in the proposed Aetna-Humana merger.
Issue Brief A proposed merger between Aetna and Humana, two of the country’s largest health insurance companies, likely would increase costs for consumers and taxpayers.
Topher Spiro and Meghan O'Toole describe how home-visiting programs can improve the lives of families in Pennsylvania and save millions of dollars for the state.
Report Creating a new Medicaid benefit for evidence-based home visiting services would simplify funding and allow states and communities to scale services, improve outcomes for families, and produce significant savings for states and the federal government.
Author Topher Spiro argues that drugs should be priced based on their effectiveness.
Report Medicare’s Pioneer ACO Model has shown modest yet improving results so far. The Centers for Medicare & Medicaid Services should make improvements to the Pioneer ACO Model while also expanding bundled payment reforms.
Report Cost shifting from employers to employees—not the Affordable Care Act—is the reason why employees continue to experience growing health care costs. Employees should be aware of these cost-shifting efforts and share in health care cost savings.
Issue Brief The new Medicare goal for payment reform is a significant milestone toward improving patient care and making health care spending more sustainable. CAP recommends these next steps to help achieve this goal.
Issue Brief The Supreme Court should not expect Congress to act to prevent disastrous consequences.
Issue Brief Targeted reforms will help more Americans afford the long-term care they are likely to need in the coming decades.
Fact Sheet New proton therapy technology costs Medicare and seniors millions of dollars but offers zero improvement for prostate cancer patients.